| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. | Director | Common Stock | 2,444,265 | $4,130,808 | $1.69 | 14 Feb 2024 | Indirect |
| Cyteir Therapeutics, Inc. | Director | Common Stock | 14,150 | $23,914 | $1.69 | 14 Feb 2024 | Direct |
| Calithera Biosciences, Inc. | Director | Stock Option (Right to Buy) | 20,000 | 11 Jun 2021 | Direct | ||
| Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 14 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919124003437-george-jean-2024-02-14 | Cyteir Therapeutics, Inc. | 14 Feb 2024 | 2 | +$23,914 | 4 | Director | 16 Feb 2024, 16:00 |
| /report/000120919123007543-george-jean-2023-02-03 | Cyteir Therapeutics, Inc. | 03 Feb 2023 | 1 | $0 | 4 | Director | 07 Feb 2023, 15:42 |
| /report/000089924322007645-george-jean-2022-02-22 | Cyteir Therapeutics, Inc. | 22 Feb 2022 | 1 | $0 | 4 | Director | 24 Feb 2022, 15:59 |
| /report/000089924321025821-george-jean-2021-06-22 | Cyteir Therapeutics, Inc. | 22 Jun 2021 | 3 | $0 | 4 | Director | 24 Jun 2021, 20:48 |
| /report/000089924321024586-george-jean-2021-06-17 | Cyteir Therapeutics, Inc. | 17 Jun 2021 | 0 | $0 | 3 | Director | 17 Jun 2021, 21:31 |
| /report/000089924321023533-george-jean-2021-06-11 | Calithera Biosciences, Inc. | 11 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 16:05 |